Application

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90592554

Filing Date: 03/21/2021

To the Commissioner for Trademarks:

MARK: VERGE (Standard Characters, see mark)
The literal element of the mark consists of VERGE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Instylla Inc., a corporation of Delaware, having an address of
      201 Burlington Road
      Bedford, Massachusetts 01730
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 010:  Catheters for use in an embolization therapy system, featuring hydrogel precursors and applicator; embolectomy catheters; catheters for use in embolization procedures; microcatheters for use in treating anomalies vasculature of the body; arterial embolectomy catheter; catheters for use in embolization therapy in interventional radiology and oncology; catheters for use in embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; catheters for use in delivery of embolic agents under fluoroscopic control; kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicator and microcatheter for delivery thereof; vascular embolization system microcatheter; catheters for use in delivery of embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis; kits for vascular embolization procedures, featuring hydrogel precursors, applicator and microcatheter; embolization catheters; embolic catheter devices for treating anomalies vasculature of the body; arterial embolectomy catheters; catheters for use in embolization therapy in interventional radiology and oncology; catheters for use in interventional radiology, namely, interventional oncology and peripheral hemostasis; catheters for use in delivery of differentiated liquid embolics; catheters for use in vascular embolization procedures; catheters for use in embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; catheters for use with syringes in the delivery of embolic agents under fluoroscopic control; kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators and catheters for delivery thereof; catheters sold as part of an embolization therapy system, featuring hydrogel precursors and applicator; catheter kit for use in embolization procedures; kits for vascular embolization procedures, featuring hydrogel precursors and applicator; catheters for delivery of differentiated liquid embolics in interventional radiology; medical apparatus and instruments for embolization; microcatheters used in treating anomalies vasculature of the body; medical device, namely, arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, delivery catheters for embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical apparatus, namely, system for vascular embolization procedures; embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis namely, embolization therapy system, featuring hydrogel precursors and applicator; kits for vascular embolization procedures, featuring hydrogel precursors and applicator.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: William E. Anderson. Other appointed attorneys are Peter Dardi; Douglas Christensen; John Fonder; Curtis Herbert. William E. Anderson of Christensen, Fonder, Dardi & Herbert PLLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      11322 86th Avenue North
      Maple Grove, Minnesota 55369
      United States
      612-315-4100(phone)
      6123154321(fax)
      anderson@cfd-ip.com
The docket/reference number is 5171.18US1.
William E. Anderson submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

William E. Anderson

PRIMARY EMAIL FOR CORRESPONDENCE: anderson@cfd-ip.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): docket@cfd-ip.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /William Anderson/   Date: 03/21/2021
Signatory's Name: William E. Anderson
Signatory's Position: Attorney of record, Minnesota bar member
Signatory's Phone Number: 612-315-4110
Signature method: Signed directly within the form
Payment Sale Number: 90592554
Payment Accounting Date: 03/22/2021

Serial Number: 90592554
Internet Transmission Date: Sun Mar 21 22:42:59 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202103212242590
06883-90592554-770f79685dd8402193d6b827e
35d9b51344b2c968e73afc370678533efffc6d-C
C-42573336-20210321223317793353